The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
A global peace advocate and founder of the Institute for Economics and Peace (IEP), Steve Killelea, has underscored the ...
Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...
Before AI, the sheer volume of data governments could collect had natural limits. Those limits no longer exist. That is the ...
Annexon Biosciences (NASDAQ:ANNX) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The company’s ...
The Raw Materials Research and Development Council (RMRDC), has launched the second generation of its national database, ...
A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...
2don MSN
Astra to seek accelerated nod for Ultomiris in IgA nephropathy after positive late-stage data
AstraZeneca (AZN) announced plans to seek accelerated approval for its rare disease therapy, Ultomiris, on Tuesday after the C5 complement inhibitor reached a key goal in a late-stage trial for ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...
In his closing remarks, Prof. Ellis Owusu-Dabo, the immediate past Pro Vice-Chancellor of the Kwame Nkrumah University of ...
Welcome to the Brady Corporation Acquisition Announcement Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference ...
As second-screen behavior rises, advertisers turn to the smart TV home screen to introduce key messages and prime viewers for ad podsNEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Nexxen, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results